Map of Scientific Uncertainty
The Scientific Question Compiler transformed a corpus on Alzheimer's & metabolic dysfunction into a structured representation of what is known, what is contested, and what is unknown. This is the inverse of a search engine: it maps the frontier, not the archive.
3
Documents
25
Claims
1
Contradictions
6
Gaps
7
Silence topics
12
Questions
Known
- Insulin receptors are widely expressed throughout the central nervous system, including the hippocampus and cortex.
- Peripheral insulin resistance is associated with reduced cerebral insulin signaling.
- Midlife insulin resistance predicts later cognitive decline and an increased risk of Alzheimer's disease.
- Exercise improves peripheral insulin sensitivity.
- Exercise is consistently associated with better cognitive outcomes in aging populations.
- Voluntary wheel running increases hippocampal insulin receptor signaling and enhances long-term potentiation.
- The dominant model of Alzheimer's disease centers on amyloid-beta accumulation and downstream tau pathology.
- Metabolic and vascular dysfunction are implicated as early contributors to Alzheimer's disease.
- Microglia respond to both amyloid and metabolic stress.
- Chronic neuroinflammation is consistently observed in postmortem tissue.
- Blood-brain barrier (BBB) dysfunction is recognized in early Alzheimer's disease, often preceding measurable cognitive symptoms.
- Reduced BBB insulin transport has been proposed as a mechanism by which peripheral insulin resistance could initiate neuronal insulin resistance.
- BBB breakdown correlates with synaptic loss, though some studies find synaptic decline occurs earlier than overt barrier failure.
- It remains unresolved whether BBB transport failure is a cause or a consequence of neuronal insulin resistance.
- Animal models show both causal directions between BBB transport failure and neuronal insulin resistance are plausible, while human data are correlational.
Controversial
- AMPK activation simultaneously improves cognition via autophagy promotion and suppresses memory formation by inhibiting synaptic translation, indicating opposing downstream outcomes for the same molecular target.
- The temporal hierarchy between the amyloid-tau cascade and metabolic/vascular dysfunction as primary drivers of early Alzheimer's disease remains unresolved, with competing theories suggesting either pathway may initiate or permissively enable the other.
- BBB insulin transport failure may act as either the primary cause or a secondary consequence of neuronal insulin resistance, with animal models supporting bidirectional causality while human data remain strictly correlational.
Silence Map — implied but absent
- Specific BBB cell types (pericytes, astrocytic endfeet, tight junction proteins)
- Tau pathology dynamics and its relationship to metabolic stress
- Neurotrophic factors (BDNF, IGF-1) and exercise-induced vascular remodeling
- Sex differences in insulin resistance and AD risk
- AMPK/mTOR isoform specificity and brain-region expression patterns
- Clinical trial outcomes for metabolic interventions in early-stage AD
- Systemic inflammatory markers and gut-brain axis contributions
Gaps (typed unknowns)
missing-mechanism
The corpus implies a direct causal relay from peripheral insulin resistance to hippocampal neuronal insulin resistance, but does not state whether this occurs primarily via transcytosis failure at the BBB, pericyte-mediated vascular dysregulation, or direct endothelial signaling disruption.
severity 0.85
unexplained-observation
The corpus notes synaptic decline can precede overt BBB failure, implying that synaptic vulnerability in early AD may be driven by intrinsic metabolic stress or soluble amyloid oligomers rather than solely by compromised insulin transport.
severity 0.8
missing-link
The contradictory effects of AMPK on cognition imply a context-dependent switch governed by stimulus intensity, duration, or neuronal subpopulation, but the corpus does not specify the molecular threshold or regulatory node that flips this balance.
severity 0.9
competing-theory
The corpus juxtaposes the amyloid-tau cascade with metabolic/vascular dysfunction as early AD contributors, implying these are not mutually exclusive but does not state the temporal hierarchy or whether metabolic failure is a permissive prerequisite for amyloid toxicity.
severity 0.75
missing-link
The corpus links exercise to both improved insulin sensitivity and enhanced hippocampal insulin receptor signaling, implying a mediating role for cerebral insulin signaling in exercise-induced cognitive protection, but does not state whether this relationship holds when insulin signaling is pharmacologically blocked.
severity 0.7
missing-mechanism
The corpus implies microglia serve as a convergence point for amyloid and metabolic stress, but does not state whether metabolic stress alone is sufficient to drive the chronic neuroinflammatory phenotype observed in AD, independent of amyloid deposition.
severity 0.8